Life Sciences
Today's Life Sciences companies must bring new innovations to market while managing a pipeline of potential new products and improving the productivity of Research & Development. Keeping up with changing regulatory burdens, counterfeit products, and patent expirations is also a daunting task. To remain profitable and to sustain long-term growth, companies must optimize cost to profit equations by reducing dependence on blockbuster drugs and transitioning their growth strategy to include other targeted treatments.
Key Challenges
- Changing regulatory requirements
- Preventing counterfeit products for blockbuster drugs while maintaining safety
- Reducing timelines from discovery through trials and regulatory approvals
- Lack of alignment between R & D initiatives and business priorities
Ways to Overcome Challenges
- Implement a centralized system to monitor, track and report on regulatory compliance
- Introduce processes and technologies that facilitate secured access to key intellectual property across the enterprise
- Re-use technology across different products, yielding faster time to market while decreasing total costs
- Create processes that allow for better alignment between R & D activities and strategic business objectives
How We Can Help
- Create processes that allow for better alignment between R & D activities and strategic business objectives
- Implement knowledge management systems to capture historical clinical trials and drug studies and link them to publicly available information and patents
- Create regulatory compliance reporting models to speed drug approvals and reduce time to market for new drug introductions
|
|
